Bladder pain syndrome (BPS) is a complex condition, which can have debilitating sequelae for patients. Many elements of BPS remain poorly understood including pathophysiology, diagnosis and treatment. Navigating patient care can therefore be challenging for the clinician. Management mandates a multidisciplinary and symptom-based approach. Intravesical treatments such as instillation therapies remain a cornerstone of most treatment algorithms and there are a range of agents that can be selected. This review offers an up-to-date evaluation of the evidence for these intravesical treatments.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.urology.2021.05.042 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!